NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Subscribe To Our Newsletter & Stay Updated